Author
Listed:
- K. K. Igwe
(Departmemt of Vet Biochemistry and Animal Production, Michael Okpara University of Agriculture, Umudike, Nigeria)
- O. V. Ikpeazu
(Department of Biochemistry, Abia State University, Uturu, Abia State, Nigeria)
- F. J. Amaku
(Department of Chemistry, Michael Okpara University of Agriculture, Umudike, Nigeria)
- I. E. Otuokere
(Department of Chemistry, Michael Okpara University of Agriculture, Umudike, Nigeria)
Abstract
The use of hydroxychloroquine as SARS-CoV-2 inhibitor is currently being reviewed in various clinical trials. To exhaustively assess the benefit of hydroxychloroquine in the search for SARS-CoV-2 cure, this paper repositioned hydroxychloroquine as a model for virtual screening on the ZINC database. Molecular docking studies of 5r7y with the retrieved molecules were performed. The S-score of the predicted compounds were compared with the reference inhibitor (hydroxychloroquine). After evaluating their binding energy, five compounds (ZINC52939663, ZINC21291670, ZINC12714071, ZINC40089978 and ZINC15963294) were noticed have to highest binding energy with SARS-CoV-2. The binding scores of the top five ligands were higher than that of the reference molecule. The pharmacokinetics, toxicity prediction, drug-likeness and global reactivity assessment of ZINC52939663, present the lead compound as a drug candidate with the probable capacity to inhibit SARS-CoV-2.
Suggested Citation
K. K. Igwe & O. V. Ikpeazu & F. J. Amaku & I. E. Otuokere, 2020.
"Repurposing Hydroxychloroquine as a Model Drug for the Prediction of Potential SARS-CoV-2 Inhibitor,"
European Journal of Engineering and Technology Research, European Open Science, vol. 5(9), pages 1031-1036, September.
Handle:
RePEc:epw:ejeng0:v:5:y:2020:i:9:id:62056
DOI: 10.24018/ejeng.2020.5.9.2056
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejeng0:v:5:y:2020:i:9:id:62056. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejeng .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.